This is usually the most useful question, because the answer is often different from what the compound is sold for.
Marketed for
- Autoimmune conditions
- Immune system regulation
- Chronic infection
- Longevity / immune aging
Actually studied
- Hematological Malignancies
- Locally Advanced Rectal Cancer
- Liver Cirrhosis
- Non-small Cell Lung Cancer
- Metastatic Non-small Cell Lung Cancer
- Radiotherapy
Both lists are factual. The left is what sellers claim; the right is what registered trials tested. Where they diverge, the marketing is running ahead of the research.
—Source
Checked against the public registry
This answer is generated from ClinicalTrials.gov records, counting
interventional human studies only. It is automated aggregation, not medical
advice, and no physician has reviewed it. See
how we count or open the
Thymosin α1 page
to check every trial yourself.